Impact of Fenfluramine on drop seizure frequency in adults or dose- capped patients with Lennox-Gastaut Syndrome: comparative analysis of clinical trial data

被引：0

作者：

Scheffer, I. E. ^{[1
]}

Ceulemans, B. ^{[2
]}

Sullivan, J. ^{[3
]}

Nickels, K. C. ^{[4
]}

Lagae, L. ^{[5
,6
]}

Guerrini, R. ^{[7
,8
]}

Zuberi, S. M. ^{[9
]}

Nabbout, R. ^{[10
]}

Riney, K. ^{[11
,12
]}

Polega, S. ^{[13
]}

Lothe, A. ^{[14
]}

Davis, R. ^{[15
]}

Gil-Nagel, A. ^{[16
]}

机构：

[1] Univ Melbourne, Austin & Royal Childrens Hosp, Melbourne, Australia

[2] Antwerp Univ Hosp, Dept Paediat Neurol, Antwerp, Belgium

[3] Univ Calif San Francisco, Benioff Childrens Hosp, Weill Inst Neurosci, San Francisco, CA USA

[4] Mayo Clin, Dept Neurol, Rochester, MN USA

[5] European Reference Network EpiCARE, Leuven, Belgium

[6] Univ Leuven, Dept Paediat Neurol, Leuven, Belgium

[7] Univ Florence, Anna Meyer Childrens Hosp, Pediat Neurol & Neurogenet Unit, Florence, Italy

[8] IRCCS Fdn Stella Maris, Pisa, Italy

[9] Royal Hosp Children, Paediat Neurosci Res Grp, Glasgow, Scotland

[10] Univ Paris Cite, Hop Univ Necker Enfants Malad, APHP,EPICARE, Reference Ctr Rare Epilepsies,Inst Imagine, Paris, France

[11] Queensland Childrens Hosp, Neurosci Unit, South Brisbane, Australia

[12] Univ Queensland, Sch Clin Med, St Lucia, Australia

[13] Zogenix Inc, Emeryville, CA USA

[14] Zogenix Int LTD, Maidenhead, England

[15] Neurol & Epilepsy Res Ctr, Orlando, FL USA

[16] Hosp Ruber Int, Madrid, Spain

来源：

EPILEPSIA | 2023年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

735

引用

页码：8 / 8

页数：1

共 40 条

[31] Caregiver-reported non-seizure and seizure outcomes with cannabidiol and clobazam in patients aged >2 years with Lennox-Gastaut syndrome or Dravet syndrome: A subgroup analysis of the BECOME survey [J].

Perry, M. Scott ;

Dixon-Salazar, Tracy ;

Meskis, Mary Anne ;

Danese, Sherry R. ;

Saurer, Timothy B. ;

Vyas, Kishan ;

Berg, Anne T. .

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2025, 130 :32-40

[32] Clobazam-treated patients with Lennox-Gastaut syndrome experienced fewer seizure-related injuries than placebo patients during trial OV-1012 [J].

Isojarvi, Jouko ;

Lee, Deborah ;

Peng, Guangbin ;

Sperling, Michael R. .

EPILEPSIA, 2016, 57 (06) :E113-E116

[33] Seizure-free days as a novel outcome in patients with Lennox-Gastaut syndrome: Post hoc analysis of patients receiving cannabidiol in two randomized controlled trials [J].

Auvin, Stephane ;

Nortvedt, Charlotte ;

Fuller, Douglas S. ;

Sahebkar, Farhad .

EPILEPSIA, 2023, 64 (07) :1812-1820

[34] TREATMENT WITH CANNABIDIOL (CBD) SIGNIFICANTLY REDUCES DROP SEIZURE FREQUENCY IN LENNOX-GASTAUT SYNDROME (LGS): RESULTS OF A MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (GWPCARE4) [J].

Mazurkiewicz-Beldzinska, M. ;

Thiele, E. A. ;

Benbadis, S. ;

Marsh, E. D. ;

Joshi, C. ;

French, J. A. ;

Roberts, C. ;

Taylor, A. ;

Sommerville, K. .

EPILEPSIA, 2017, 58 :S55-S55

[35] Cannabidiol (CBD) Significantly Reduces Drop and Total Seizure Frequency in Lennox Gastaut Syndrome (LGS): Results of a Dose Ranging, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (GWPCARE3) [J].

Wirrell, E. ;

Devinsky, O. ;

Patel, A. ;

Zuberi, S. ;

Cross, J. ;

Villanueva, V. ;

Roberts, C. ;

Checketts, D. ;

VanLandingham, K. .

ANNALS OF NEUROLOGY, 2017, 82 :S279-S280

[36] CLINICAL AND HEALTHCARE RESOURCE BURDEN OF DISEASE IN PATIENTS WITH LENNOX-GASTAUT SYNDROME (LGS): RESULTS FROM A US CLAIMS MATCHED-CONTROL ANALYSIS [J].

Lu, M. ;

Ma, X. ;

Yung, E. ;

Noman, A. ;

Ip, Q. ;

Wei, Y. ;

Rao, S. .

VALUE IN HEALTH, 2024, 27 (06) :S145-S146

[37] The effect of a ketogenic diet on cannabidiol plasma concentration and seizure reduction in patients with Lennox- Gastaut syndrome or Dravet syndrome: Post-hoc analysis of data from the randomised controlled trials [J].

Landmark, C. Johannessen ;

McCarter, M. ;

Meinilid, H. ;

Vyas, K. .

EPILEPSIA, 2024, 65 :457-458

[38] Efficacy of Adjunctive Eslicarbazepine Acetate in Patients with Focal Seizures, According to Baseline Seizure Frequency: A Post-Hoc Analysis of Data from a Phase IV Clinical Trial [J].

Aboumatar, Sami ;

Cantu, David ;

Blum, David ;

Zhang, Ian ;

Grinnell, Todd .

NEUROLOGY, 2021, 96 (15)

[39] Defining a Minimal Clinically Important Difference in Seizure Frequency Using Data from a Phase 3 Clinical Study of Add-On, Low-Dose ZX008 (Fenfluramine HCl Oral Solution) in Dravet Syndrome Patients Receiving an Antiepileptic Drug Regimen Containing Stiripentol [J].

Gammaitoni, A. ;

Sullivan, J. ;

Dlugos, D. ;

Farfel, G. ;

Galer, B. ;

Morrison, G. ;

Haney, D. ;

Nabbout, R. .

ANNALS OF NEUROLOGY, 2019, 86 :S61-S61

[40] Profound Reduction in Seizure Frequency (≥75%) Leads to Improved Everyday Executive Function in Patients with Dravet Syndrome at 1 Year Post-treatment with ZX008 (Fenfluramine HCl Oral Solution): Analysis of Data From the Phase 3 Clinical Development Program [J].

Bishop, Kim ;

Isquith, Peter ;

Gioia, Gerard ;

Morrison, Glenn ;

Haney, Douglas ;

Gammaitoni, Arnold .

NEUROLOGY, 2020, 94 (15)

← 1 2 3 4 →